Borderline ovarian tumors: Key points and workshop summary

被引：105

作者：

Silverberg, SG

Bell, DA

Kurman, RJ

Seidman, JD

Prat, J

Ronnett, BM

Copeland, L

Silva, E

Gorstein, F

Young, RH

机构：

[1] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA

[2] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA

[3] Harvard Univ, Sch Med, Boston, MA USA

[4] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD USA

[5] Johns Hopkins Univ, Sch Med, Dept Gynecol, Baltimore, MD USA

[6] Johns Hopkins Univ, Sch Med, Dept Obstet, Baltimore, MD USA

[7] Washington Hosp Ctr, Dept Pathol, Washington, DC 20010 USA

[8] Univ Autonoma Barcelona, Hosp Santa Creu Sant Pau, Dept Pathol, Barcelona, Spain

[9] Ohio State Univ, James Canc Ctr, Dept Obstet & Gynecol, Columbus, OH USA

[10] Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA

[11] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA

来源：

HUMAN PATHOLOGY | 2004年 / 35卷 / 08期

关键词：

ovary; borderline tumor; low malignant potential; atypical proliferative; serous; mucinous;

D O I：

10.1016/j.humpath.2004.03.003

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

This article documents major points of agreement and disagreement among experts invited to participate in a Borderline Ovarian Tumor Workshop held in Bethesda, MD, on August 27-28, 2003. It is suggested that controversies related to the diagnosis and management of these tumors are often related to lack of data in the literature (small numbers of cases, unreported or unclear criteria for diagnosis and follow-up, insufficient length of follow-up, etc), and specific recommendations are made for further investigation and for reporting of data in future studies. (C) 2004 Elsevier Inc. All rights reserved.

引用

页码：910 / 917

页数：8

共 50 条

[1] [Anonymous], 2003, PATHOLOGY GENETICS T
[2] BELL DA, 1988, CANCER, V62, P2212, DOI 10.1002/1097-0142(19881115)62:10<2212::AID-CNCR2820621024>3.0.CO
[3] 2-W
[4] OVARIAN SEROUS BORDERLINE TUMORS WITH STROMAL MICROINVASION - A REPORT OF 21 CASES
BELL, DA
SCULLY, RE
[J]. HUMAN PATHOLOGY, 1990, 21 (04) : 397 - 403
[5] Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas
Bell, KA
Sehdev, AES
Kurman, RJ
[J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (04) : 419 - 432
[6] BOSTWICK DG, 1986, CANCER, V58, P2052, DOI 10.1002/1097-0142(19861101)58:9<2052::AID-CNCR2820580916>3.0.CO
[7] 2-5
[8] Micropapillary serous carcinoma of the ovary - A distinctive low-grade carcinoma related to serous borderline tumors
Burks, RT
Sherman, ME
Kurman, RJ
[J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (11) : 1319 - 1330
[9] Epithelial ovarian tumors of low malignant potential: The role of microinvasion
Buttin, BM
Herzog, TJ
Powell, MA
Rader, JS
Mutch, DG
[J]. OBSTETRICS AND GYNECOLOGY, 2002, 99 (01) : 11 - 17
[10] Clement PB, 1996, MODERN PATHOL, V9, P879

← 1 2 3 4 5 →